Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Customer Center
Customer Center
Case Studies Clients Testimonials Downloads Partnerships Intellectual Property Protection Newsletters
HomeClient CenterMedicilon SupportIND 100
IND 100 Publications
Oct 29,2019
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Medicilon has currently completed the pharmacokinetic study of common insulin and oral insulin compound preparations of a company in Jiangsu, administered the test product subcutaneously and orally, and measured the blood glucose level of animals with a Roche blood glucose meter;
See More
Insulin Technology Achieves a New Breakthrough, Medicilon Helps to Make a New Leap Forward!
Jun 07,2019
Medicilon helps ImmuneOnco Biopharma's target CD47 fusion protein drug to obtain NMPA clinical trial license
Recently, ImmuneOnco Biopharma, a partner of Shanghai Medicilon Inc., announced that its newly developed immune checkpoint inhibitor has been approved by the National Medical Products Administration (NMPA), which marks the beginning of a new phase of research on the first CD47 fusion protein drug in China. It is reported that ImmuneOnco Biopharma submitted the INDRead more
See More
Medicilon helps ImmuneOnco Biopharma's target CD47 fusion protein drug to obtain NMPA clinical trial license
Jul 02,2018
Huizhou Jizhong Biological Technology's Biological New Drug Obtained FDA Clinical Approval!
Recently, Huizhou Jizhong Biological Technology's innovative drug local anesthetic injection - a new long-acting postoperative analgesic successfully obtained FDA (US Food and Drug Administration) new drug clinical trial approval!
See More
Huizhou Jizhong Biological Technology's Biological New Drug Obtained FDA Clinical Approval!
May 15,2018
Medicilon Assist: Haihe Biopharma and 3D Medicines Start Cooperation on New Anti-tumor Drugs
Haihe Biopharma and 3D Medicines announced on April 28 that the two parties have reached a strategic cooperation on the FGFR inhibitor (code-named "HH185") project of Haihe Biopharma.
See More
Medicilon Assist: Haihe Biopharma and 3D Medicines Start Cooperation on New Anti-tumor Drugs
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->